IPOs this week : Feb. 11 - 15, 2019

IPOs expected to price:

• Anchiano Therapeutics (ANCN) on February 11; 
• Virgin Trains USA (VTUS) on February 12; 
• TCR2 Therapeutics (TCRR), 
• Cibus (CBUS) and Avedro (AVDR) on February 13; 
• Stealth BioTherapeutics (MITO) on February 14.

IPO activity: In case you missed it, the IPO market was lit up with the news that Postmates (POSTM) and Slack (SLACK) filed for confidential listings.

There are IPO share lock-up expirations upcoming on Avalon GloboCare (OTCQB:AVCO) and Aridis Pharmaceuticals (NASDAQ:ARDS) on February 12 and Safe-T (NASDAQ:SFET) on February 13.

Calyxt (CLXT) : 2-month performance

• IPO: 20 July 2017
• Merged wih Cibus (Nasdaq: CBUS)  (June 01, 2023)

Calyxt, Inc. is a food and agriculture company. The Company is focused on delivering healthier specialty food ingredients, such as healthier oils and high fiber wheat, for consumers and agriculturally advantageous crop traits, such as herbicide tolerance to farmers. The Company also combines gene-editing technology and technical that enables to edit a plant genome to elicit the desired traits and characteristics. The Company products include Consumer Centric and Farmer Centric products. Consumer Centric product, which includes high oleic soybean, high fiber wheat, high fiber wheat II, reduced gluten wheat, cold storable potato and reduced browning potato. Farmer Centric products, which includes drought tolerant soybean, improved soybean, herbicide tolerant wheat, herbicide tolerant canola, herbicide tolerant alfalfa and herbicide quality alfalfa.The Company has several products under development including high oleic soybeans, powdery mildew resistant wheat and cold storable potato.

Address

600 County Road D W Ste 8
NEW BRIGHTON, MN 55112-3519
United States

Website 

http://www.calyxt.com

Key stats and ratios

	Q2 (Jun '17)	2016
Net profit margin	-1522.42%	-3029.07%
Operating margin	-1452.91%	-3034.84%
EBITD margin	-	-2948.37%
Return on average assets	-85.03%	-56.72%
Return on average equity	-151.26%	-64.67%
Employees	27